Source:http://linkedlifedata.com/resource/pubmed/id/20147530
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-2-11
|
pubmed:abstractText |
Endocannabinoids (eCBs) function as retrograde signaling molecules at synapses throughout the brain, regulate axonal growth and guidance during development, and drive adult neurogenesis. There remains a lack of genetic evidence as to the identity of the enzyme(s) responsible for the synthesis of eCBs in the brain. Diacylglycerol lipase-alpha (DAGLalpha) and -beta (DAGLbeta) synthesize 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain. However, their respective contribution to this and to eCB signaling has not been tested. In the present study, we show approximately 80% reductions in 2-AG levels in the brain and spinal cord in DAGLalpha(-/-) mice and a 50% reduction in the brain in DAGLbeta(-/-) mice. In contrast, DAGLbeta plays a more important role than DAGLalpha in regulating 2-AG levels in the liver, with a 90% reduction seen in DAGLbeta(-/-) mice. Levels of arachidonic acid decrease in parallel with 2-AG, suggesting that DAGL activity controls the steady-state levels of both lipids. In the hippocampus, the postsynaptic release of an eCB results in the transient suppression of GABA-mediated transmission at inhibitory synapses; we now show that this form of synaptic plasticity is completely lost in DAGLalpha(-/-) animals and relatively unaffected in DAGLbeta(-/-) animals. Finally, we show that the control of adult neurogenesis in the hippocampus and subventricular zone is compromised in the DAGLalpha(-/-) and/or DAGLbeta(-/-) mice. These findings provide the first evidence that DAGLalpha is the major biosynthetic enzyme for 2-AG in the nervous system and reveal an essential role for this enzyme in regulating retrograde synaptic plasticity and adult neurogenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-arachidonylglycerol,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Endocannabinoids,
http://linkedlifedata.com/resource/pubmed/chemical/Glycerides,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoprotein Lipase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1529-2401
|
pubmed:author |
pubmed-author:BatesBrianB,
pubmed-author:DengKangwenK,
pubmed-author:DohertyPatrickP,
pubmed-author:GaoYingY,
pubmed-author:GoncalvesMaria BeatrizMB,
pubmed-author:HobbsCarlC,
pubmed-author:HowellFiona VFV,
pubmed-author:KouranovaEvguenia VEV,
pubmed-author:LuPeiminP,
pubmed-author:MarkLillyL,
pubmed-author:PangalosMenelas NMN,
pubmed-author:PieslaMichael JMJ,
pubmed-author:ReisenbergMelinaM,
pubmed-author:RingRobert HRH,
pubmed-author:SamadTarek ATA,
pubmed-author:StrassleBrian WBW,
pubmed-author:TengC TCT,
pubmed-author:VasilyevDmitry VDV,
pubmed-author:WalshFrank SFS,
pubmed-author:WhitesideGarth TGT,
pubmed-author:WilliamsGarethG,
pubmed-author:ZhangMei-YiMY
|
pubmed:issnType |
Electronic
|
pubmed:day |
10
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2017-24
|
pubmed:meshHeading |
pubmed-meshheading:20147530-Animals,
pubmed-meshheading:20147530-Arachidonic Acids,
pubmed-meshheading:20147530-Brain,
pubmed-meshheading:20147530-Endocannabinoids,
pubmed-meshheading:20147530-Glycerides,
pubmed-meshheading:20147530-Hippocampus,
pubmed-meshheading:20147530-Lipoprotein Lipase,
pubmed-meshheading:20147530-Liver,
pubmed-meshheading:20147530-Mice,
pubmed-meshheading:20147530-Mice, Knockout,
pubmed-meshheading:20147530-Neurogenesis,
pubmed-meshheading:20147530-Neuronal Plasticity,
pubmed-meshheading:20147530-Signal Transduction,
pubmed-meshheading:20147530-Spinal Cord,
pubmed-meshheading:20147530-Synapses
|
pubmed:year |
2010
|
pubmed:articleTitle |
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice.
|
pubmed:affiliation |
Neuroscience Discovery, Pfizer Research, Princeton, New Jersey 08543, and Wolfson Centre for Age-Related Diseases, King's College London, London SE1 1UL, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|